BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9869597)

  • 1. Conjugated bile acid replacement therapy for short-bowel syndrome.
    Gruy-Kapral C; Little KH; Fordtran JS; Meziere TL; Hagey LR; Hofmann AF
    Gastroenterology; 1999 Jan; 116(1):15-21. PubMed ID: 9869597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon.
    Kapral C; Wewalka F; Praxmarer V; Lenz K; Hofmann AF
    Z Gastroenterol; 2004 Jul; 42(7):583-9. PubMed ID: 15248106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome.
    Heydorn S; Jeppesen PB; Mortensen PB
    Scand J Gastroenterol; 1999 Aug; 34(8):818-23. PubMed ID: 10499484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome.
    Emmett M; Guirl MJ; Santa Ana CA; Porter JL; Neimark S; Hofmann AF; Fordtran JS
    Am J Kidney Dis; 2003 Jan; 41(1):230-7. PubMed ID: 12500242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Studies in dogs with ileal resection.
    Longmire-Cook SJ; Lillienau J; Kim YS; Schteingart CD; Danzinger RG; Esch O; Hofmann AF
    Dig Dis Sci; 1992 Aug; 37(8):1217-27. PubMed ID: 1379904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cholysarkosin in treatment of bile acid deficiency syndrome].
    Weinand I; Stein J
    Z Gastroenterol; 1999 Jul; 37(7):675-7. PubMed ID: 10458016
    [No Abstract]   [Full Text] [Related]  

  • 7. Enteric-coated cholylsarcosine microgranules for the treatment of short bowel syndrome.
    Fürst T; Bott C; Stein J; Dressman JB
    J Pharm Pharmacol; 2005 Jan; 57(1):53-60. PubMed ID: 15638993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorder of bile acid metabolism in children with short bowel syndrome.
    Ohkohchi N; Andoh T; Izumi U; Igarashi Y; Ohi R
    J Gastroenterol; 1997 Aug; 32(4):472-9. PubMed ID: 9250893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine.
    Lillienau J; Schteingart CD; Hofmann AF
    J Clin Invest; 1992 Feb; 89(2):420-31. PubMed ID: 1371123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ox bile treatment of severe steatorrhea in an ileectomy-ileostomy patient.
    Fordtran JS; Bunch F; Davis GR
    Gastroenterology; 1982 Mar; 82(3):564-8. PubMed ID: 7054048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans.
    Schmassmann A; Fehr HF; Locher J; Lillienau J; Schteingart CD; Rossi SS; Hofmann AF
    Gastroenterology; 1993 Apr; 104(4):1171-81. PubMed ID: 7681796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon as a digestive organ in patients with short bowel.
    Nordgaard I; Hansen BS; Mortensen PB
    Lancet; 1994 Feb; 343(8894):373-6. PubMed ID: 7905549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy absorption is reduced with oleic acid supplements in human short bowel syndrome.
    Compher CW; Kinosian BP; Rubesin SE; Ratcliffe SJ; Metz DC
    JPEN J Parenter Enteral Nutr; 2009; 33(1):102-8. PubMed ID: 19028932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study.
    Buchman AL; Fryer J; Wallin A; Ahn CW; Polensky S; Zaremba K
    JPEN J Parenter Enteral Nutr; 2006; 30(6):487-91. PubMed ID: 17047172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport, metabolism, and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dehydroxylation.
    Schmassmann A; Angellotti MA; Ton-Nu HT; Schteingart CD; Marcus SN; Rossi SS; Hofmann AF
    Gastroenterology; 1990 Jan; 98(1):163-74. PubMed ID: 1688373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats.
    Lorenzo-Zúñiga V; Bartolí R; Planas R; Hofmann AF; Viñado B; Hagey LR; Hernández JM; Mañé J; Alvarez MA; Ausina V; Gassull MA
    Hepatology; 2003 Mar; 37(3):551-7. PubMed ID: 12601352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic digestion and absorption of energy from carbohydrates and medium-chain fat in small bowel failure.
    Jeppesen PB; Mortensen PB
    JPEN J Parenter Enteral Nutr; 1999; 23(5 Suppl):S101-5. PubMed ID: 10483907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a fat-reduced diet on the faecal excretion of radioactivity following administration of 14C-cholic acid and on the duodenal concentration of bile salts in patients with ileal disease.
    Andersson H
    Nutr Metab; 1976; 20(4):254-63. PubMed ID: 1029814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of bile acids in the pathogenesis of chronic diarrhea].
    Krums LM; Gubina AV; Parfenov AI; Sil'vestrova SIu
    Eksp Klin Gastroenterol; 2012; (3):35-9. PubMed ID: 22830222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy absorption as a measure of intestinal failure in the short bowel syndrome.
    Rodrigues CA; Lennard-Jones JE; Thompson DG; Farthing MJ
    Gut; 1989 Feb; 30(2):176-83. PubMed ID: 2495238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.